Alyeska Investment Group L.P. purchased a new stake in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 284,219 shares of the company's stock, valued at approximately $40,422,000. Alyeska Investment Group L.P. owned approximately 0.09% of Kimberly-Clark as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of KMB. GAMMA Investing LLC lifted its position in Kimberly-Clark by 10,975.8% during the first quarter. GAMMA Investing LLC now owns 1,902,050 shares of the company's stock valued at $270,510,000 after buying an additional 1,884,877 shares in the last quarter. Pacer Advisors Inc. lifted its position in Kimberly-Clark by 2,982.8% during the first quarter. Pacer Advisors Inc. now owns 1,384,318 shares of the company's stock valued at $196,878,000 after buying an additional 1,339,413 shares in the last quarter. Trinity Financial Advisors LLC acquired a new position in Kimberly-Clark during the first quarter valued at approximately $181,762,000. Nuveen LLC acquired a new position in Kimberly-Clark during the first quarter valued at approximately $106,458,000. Finally, OVERSEA CHINESE BANKING Corp Ltd lifted its position in Kimberly-Clark by 270.2% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 984,695 shares of the company's stock valued at $140,043,000 after buying an additional 718,720 shares in the last quarter. 76.29% of the stock is owned by institutional investors and hedge funds.
Kimberly-Clark Trading Down 0.7%
KMB opened at $128.00 on Thursday. The stock has a market capitalization of $42.47 billion, a PE ratio of 16.95, a P/E/G ratio of 4.46 and a beta of 0.32. The firm's fifty day moving average price is $130.48 and its 200 day moving average price is $135.00. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54. Kimberly-Clark Co. has a 12-month low of $124.10 and a 12-month high of $150.45.
Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.67 by $0.25. The firm had revenue of $4.16 billion for the quarter, compared to analysts' expectations of $4.85 billion. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The firm's quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.96 earnings per share. As a group, research analysts expect that Kimberly-Clark Co. will post 7.5 EPS for the current fiscal year.
Kimberly-Clark Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Friday, September 5th will be paid a dividend of $1.26 per share. The ex-dividend date is Friday, September 5th. This represents a $5.04 annualized dividend and a yield of 3.9%. Kimberly-Clark's payout ratio is presently 69.42%.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. JPMorgan Chase & Co. upgraded shares of Kimberly-Clark from an "underweight" rating to a "neutral" rating and lifted their price objective for the company from $125.00 to $138.00 in a research note on Monday, August 4th. Barclays lifted their price objective on shares of Kimberly-Clark from $134.00 to $139.00 and gave the company an "equal weight" rating in a research note on Monday, August 4th. UBS Group dropped their price objective on shares of Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a research note on Thursday, July 17th. Finally, Piper Sandler assumed coverage on shares of Kimberly-Clark in a research note on Friday, July 18th. They set an "overweight" rating and a $144.00 price objective on the stock. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $142.70.
Read Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Company Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.